Enquiry/Quote
ELTROMBOPAG Solution bulk supplier for pharma manufacturers

Eltrombopag Solution Suppliers & Bulk Manufacturers

Available Forms: Oral Solution

Available Strengths: 12.5 mg, 25mg

Reference Brands: Promacta (USA)

Category: Hepatitis

This tablet contains the active constituent eltrombopag. It is used to treat low platelet counts caused by immune primary thrombocytopenia (ITP) or hepatitis C virus (HCV) infection. ELTROMBOPAG Solution is available in Oral Solution and strengths such as 12.5 mg, 25mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, ELTROMBOPAG Solution is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

ELTROMBOPAG Solution can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Platelets are blood cells that help seal cuts and form blood cuts, and very low platelet counts can lead to serious bleeding and bruising. It is also used in adults to treat low blood counts caused by severe aplastic anemia (SAA).

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Eltrombopag choline is used to treat thrombocytopenia by increasing platelet production. It is commonly prescribed for chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia associated with chronic hepatitis C.

Eltrombopag choline is a synthetic small-molecule thrombopoietin receptor agonist formulated as a choline salt for oral administration.

Eltrombopag choline is marketed under the trade names Promacta in the USA and Revolade in the EU and UK.

Eltrombopag choline products are manufactured by multiple pharmaceutical companies, including the original innovator and licensed generic manufacturers, depending on the market.

The generic name is eltrombopag choline.

The brand names are Promacta in the USA and Revolade in the EU and UK.

Eltrombopag choline formulations are manufactured in various countries including the USA, EU, and India, depending on the approved manufacturer and regulatory authorizations.

Yes, ELTROMBOPAG Solution is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, ELTROMBOPAG Solution is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir

Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)

Form: Tablet

Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)

View Details
Glecaprevir/Pibrentasvir

Strength:
Glecaprevir 100 mg Pibrentasvir 40 mg

Form: Oral tablets

Reference Brands: Mavyret®

View Details
Ribavirin

Strength:
Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL

Form: Tablets, Capsules and Oral Solution

Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)

View Details
Adefovir Dipivoxil

Strength:
10 mg

Form: Oral tablets

Reference Brands: Hepsera® (EU & US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.